Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Go back to Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule| (NASDAQ: LEXX) | Delayed: 10.35 -1.33 (11.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.68 | 52 Week High | $ | |||
| Open | $11.42 | 52 Week Low | $ | |||
| Day High | $12.48 | P/E | N/A | |||
| Day Low | $10.35 | EPS | $ | |||
| Volume | 61,908 | |||||
